ENTHESITIS-RELATED ARTHRITIS (ERA)

Clinical trials for ENTHESITIS-RELATED ARTHRITIS (ERA) explained in plain language.

Never miss a new study

Get alerted when new ENTHESITIS-RELATED ARTHRITIS (ERA) trials appear

Sign up with your email to follow new studies for ENTHESITIS-RELATED ARTHRITIS (ERA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can kids with arthritis safely reduce their medication?

Disease control Not yet recruiting

This study aims to understand the best long-term treatment approaches for children and teenagers with specific types of juvenile arthritis (ERA or JPsA) who are taking the drug secukinumab and have achieved inactive disease. Researchers will use data from a German registry to see…

Matched conditions: ENTHESITIS-RELATED ARTHRITIS (ERA)

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 02, 2026 05:42 UTC

ENTHESITIS-RELATED ARTHRITIS (ERA)

Get alerted when new ENTHESITIS-RELATED ARTHRITIS (ERA) trials appear

Can kids with arthritis safely reduce their medication?